The Patent Finder

MSH Biopharma, Inc.

Also on record
Records under this name other than patents MSH Biopharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to MSH Biopharma, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,800,291Uro-genital condition treatment system
Term ended
Ended no later than Mar 23, 2020 · USPTO record
Term endedEnded no later than Mar 23, 2020USPTO record
US 6,894,028Use of KPV tripeptide for dermatological disorders
Lapsed on the fee record
Ended May 17, 2017 · USPTO record
Lapsed on the fee recordEnded May 17, 2017USPTO record
US 7,244,710Treatment of ophthalmic infections using antimicrobial peptides
Lapsed on the fee record
Ended Jul 17, 2015 · USPTO record
Lapsed on the fee recordEnded Jul 17, 2015USPTO record
US 7,232,804Use of KPV tripeptide for dermatological disorders
Lapsed on the fee record
Ended Jun 19, 2015 · USPTO record
Lapsed on the fee recordEnded Jun 19, 2015USPTO record
US 7,115,574System and method for support legacy operating system booting in a legacy-free system
Lapsed on the fee record
Ended Oct 3, 2014 · USPTO record
Lapsed on the fee recordEnded Oct 3, 2014USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited